microcal s origin 8 0 software (Malvern Panalytical)
Malvern Panalytical is a verified supplier 
Malvern Panalytical manufactures this product 
86
Structured Review
Malvern Panalytical
microcal s origin 8 0 software
Microcal S Origin 8 0 Software, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microcal+origin+8+0+software/pm41115540-90-4-4
Average 86 stars, based on 1 article reviews
Microcal S Origin 8 0 Software, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microcal+origin+8+0+software/pm41115540-90-4-4
Average 86 stars, based on 1 article reviews
microcal s origin 8 0 software - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Software:Article Title: Structure-based investigation of MARK4 inhibitory potential of Naringenin for therapeutic management of cancer and neurodegenerative diseases. Article Snippet: Funding information National Medicinal Plants Board, Ministry of AYUSH, Government of India, Grant/Award Number: Z.18017/ 187/CSS/R&D/DL‐01/2019‐20‐NMPB‐ IVA; Taif University, Grant/Award Number: TURSP‐2020/131 Abstract MAP/microtubule affinity‐regulating kinase 4 (MARK4) is a member of serine/threonine kinase family and considered an attractive drug target for many diseases.. Screening of Indian Medicinal Plants, Phytochemistry, and Therapeutics (IMPPAT) using virtual high‐throughput screening coupled with enzyme assay suggested that Naringenin (NAG) could be a potent inhibitor of MARK4.. Structure‐based molecular docking analysis showed that NAG binds to the critical residues found in the active site pocket of MARK4. Article Title: Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70. Article Snippet: .. Article Title: Characterization of an Escherichia coli -derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70 Article Snippet: .. |